No CrossRef data available.
Article contents
Response to: Management of Seizures and Epilepsy in Patients with Autoimmune Encephalitis
Published online by Cambridge University Press: 29 April 2024
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0317167124000647/resource/name/firstPage-pdf-S0317167124000647a.jpg)
Keywords
- Type
- Letters to the Editor: Published Article
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation
References
Hahn, C, Budhram, A, Alikhani, K, et al. Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults. Can J Neurol Sci. 2024:1–21.Google ScholarPubMed
de Bruijn, MAAM, van Sonderen, A, van Coevorden-Hameete, MH, et al. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA. Neurology. 2019;92:e2185–e96.CrossRefGoogle ScholarPubMed
Liu, X, Guo, K, Lin, J, et al. Long-term seizure outcomes in patients with autoimmune encephalitis: a prospective observational registry study update. Epilepsia. 2022;63:1812–21.CrossRefGoogle ScholarPubMed
Smith, KM, Britton, JW, Thakolwiboon, S, et al. Seizure characteristics and outcomes in patients with neurological conditions related to high-risk paraneoplastic antibodies. Epilepsia. 2023;64:2385–98.CrossRefGoogle ScholarPubMed
Malter, MP, Frisch, C, Zeitler, H, et al. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure. 2015;30:57–63.CrossRefGoogle ScholarPubMed
Serrano-Castro, PJ, Rodríguez-Uranga, JJ, Cabezudo-García, P, et al. Cenobamate and clobazam combination as personalized medicine in autoimmune-associated epilepsy with Anti-Gad65 antibodies. Neurol Neuroimmunol Neuroinflamm. 2023;10:e200151.CrossRefGoogle ScholarPubMed
Mäkelä, KM, Hietaharju, A, Brander, A, Peltola, J. Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol. 2018;9:579.CrossRefGoogle ScholarPubMed
Carreño, M, Bien, CG, Asadi-Pooya, AA, et al. Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res. 2017;129:101–5.CrossRefGoogle ScholarPubMed